Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Non-Tech : CGPR CONSOLIDATED GROWRS & PROCESRS -- Ignore unavailable to you. Want to Upgrade?

To: Will Gamble who wrote (24)	4/22/1999 2:43:00 PM
From: dirtroad	Read Replies (1) \| Respond to of 47

Will, glad to hear that things are looking good for you. If you would like a little syrup for your pancakes, here is another news release: Thursday April 22, 7:32 am Eastern Time Company Press Release Noted Plant Biologist Dr. Slavik Dushenkov Joins Consolidated Growers & Processors MONTEREY, Calif.--(BUSINESS WIRE)--April 22, 1999--One month after the March 15 announcement that DuPont Co. sought to pay $7.7 billion for leading seed producer Pioneer Hi-Bred International Inc., Consolidated Growers & Processors Inc. (OTC/BB: CGPR - news), the first multinational industrial hemp company, has announced that renowned plant biologist Dr. Slavik Dushenkov has joined the company to head its biotechnology and seed breeding units. Dushenkov will oversee a sophisticated biotech development program for industrial hemp similar to that which made Pioneer Hi-Bred International valuable for corn. A leading scientist in the areas of plant biology and phytoremediation (using plants to clean contaminated soil), Dushenkov is also the author of numerous books and scientific publications in the field. As a visiting research professor at Rutgers University, Dushenkov will oversee and coordinate the CGP research program being conducted at Photosynthetic Harvest Inc. (PHI), the corporate research affiliate of Rutgers. On April 8 CGP finalized its agreement with PHI, paving the way for the development of novel nutraceutical and pharmaceutical products derived from hemp. Of the hiring of Dushenkov, CGP chief executive officer Larry Siddens stated, ''We are honored to welcome Dr. Dushenkov to our staff and anticipate that his work will be integral in revealing the full potential of hemp as it benefits human beings.'' With hemp oil already recognized for its anti-oxidant qualities, CGP is planning to announce a line of trademarked hemp oil and hemp seed products known as ''H3(OMEGA SYMBOL)'' later this year. Global sales of hemp, a versatile and environmentally friendly crop grown legally in two dozen countries, are ''booming,'' according to U.S. News & World Report. Having made substantial inroads in the sale of raw materials, CGP also seeks to produce value-added products such as nutraceuticals and pharmaceuticals, high-nutrient foods, supplements and cosmetics as well as fine fiber for use in autos and insulation and fiber for paper products, plastics and metals. On April 9 CGP's Canadian subsidiary announced the choice of Dauphin, Manitoba as the site for two processing facilities -- the largest of their kind in the Western Hemisphere -- which, at full capacity, will process up to 100,000 tons of hemp straw and 15,000 tons of hemp seed annually. Contact: B/W/R, Los Angeles Robin Weitz or Larry Winokur 310/248-6107 or 310/248-6137 Fax: 310/550-1701 E-mail: rweitz@bwr-la.com or lwinokur@bwr-la. Later, dirtroad